J 2022

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

PAGANO, Livio, Jon SALMANTON-GARCÍA, Francesco MARCHESI, Alberto LÓPEZ-GARCÍA, Sylvain LAMURE et. al.

Basic information

Original name

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Authors

PAGANO, Livio (guarantor), Jon SALMANTON-GARCÍA, Francesco MARCHESI, Alberto LÓPEZ-GARCÍA, Sylvain LAMURE, Federico ITRI, Maria GOMES-SILVA, Giulia DRAGONETTI, Iker FALCES-ROMERO, Jaap van DOESUM, Uluhan SILI, Jorge LABRADOR, Maria CALBACHO, Yavuz M BILGIN, Barbora WEINBERGEROVÁ (203 Czech Republic, belonging to the institution), Laura SERRANO, José-María Ribera-Santa SUSANA, Sandra MALAK, José LOUREIRO-AMIGO, Andreas GLENTHØJ, Raúl CÓRDOBA-MASCUÑANO, Raquel NUNES-RODRIGUES, Tomás-José GONZÁLEZ-LÓPEZ, Linda Katharina KARLSSON, María-Josefa JIMÉNEZ-LORENZO, José-Ángel HERNÁNDEZ-RIVAS, Ozren JAKSIC, Zdeněk RÁČIL, Alessandro BUSCA, Paolo CORRADINI, Martin HOENIGL, Nikolai KLIMKO, Philipp KOEHLER, Antonio PAGLIUCA, Francesco PASSAMONTI and Oliver A CORNELY

Edition

Blood, Washington DC, USA, American Society of Hematology, 2022, 0006-4971

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 20.300

RIV identification code

RIV/00216224:14110/22:00125822

Organization unit

Faculty of Medicine

UT WoS

000769559500020

Keywords in English

COVID-19; patients with hematological malignancies; vaccination; EPICOVIDEHA

Tags

Tags

International impact, Reviewed
Změněno: 16/5/2022 13:54, Mgr. Tereza Miškechová

Abstract

V originále

Coronavirus disease 2019 (COVID-19) is a life-threatening condition of high relevance for comorbid patients, such as those with baseline hematological malignancies (HM). In April 2020, the European Hematology Association - Infectious Diseases Working Party opened an open web-based registry to collect all cases of HM adult patients that developed COVID-19 infections (EPICOVIDEHA survey). This registry aimed to describe the epidemiology, risk factors, and mortality rates of HM patients. Overall, we collected 3801 valid cases, and we observed an overall mortality rate of 31%.